Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-01-22

Clinical Trial Update: Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study [Phase 3]

View source ↗

Summary

This document provides a clinical trial update on the NICHE Phase 3 study evaluating nitrates in combination with hydralazine for cardiorenal syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydralazine (hydralazine)
  • Nitrates (nitrate)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Cardio-Renal Syndrome | Phase 3 | Status: UNKNOWN